Viking Therapeutics Has $502 Million in Cash and 1 Big Catalyst Left in 2026 -- Is That Enough?

Investor sentiment on the key benefit of its lead drug candidate could be impacted in the current quarter.

CryptoAlerta — análise de criptomoedas e mercado em tempo real